Mylan Doxycycline Hyclate tablets win FDA ANDA approval - Pharmaceutical Business Review
Proactive Investors AustraliaMylan Doxycycline Hyclate tablets win FDA ANDA approvalPharmaceutical Business ReviewMylan Pharmaceuticals has received Abbreviated New Drug Application (ANDA) acceptance from the US Food and Drug Administration (FDA) for its Doxycycline Hyclate Delayed-release (DR) tablets USP, 150 mg.
Premier Surgeon: Managing the ocular surface - OSN SuperSite
OSN SuperSitePremier Surgeon: Managing the ocular surfaceOSN SuperSite.
Gonorrhea Resistant to Antibiotics on the Rise - ABC News (blog)
Private MDGonorrhea Resistant to Antibiotics on the RiseABC News (blog)But, the most jarring part of the problem, authors note, is that the antibiotic used today to treat the infection is the last one left among the recommended antibiotics by the CDC, when taken along with doxycycline or azithromycin, two other oral .
Literatus: Deadly nature and leptospirosis - Sun.Star
Literatus: Deadly nature and leptospirosisSun.
FDA pulls Impax antibiotic dose as it approves Mylan version - San Francisco Business Times (blog)
FDA pulls Impax antibiotic dose as it approves Mylan versionSan Francisco Business Times (blog)All doses of Doryx, or doxycycline hyclate delayed-release tablets, had US sales of about $264.